| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Mar 14, 2024 | Buy | $11.31 | 4,400 | 49,771 | 171,620 | Mar 18, 2024, 04:06 PM | |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | Director | Dec 13, 2021 | Sale | $27.36 | 325,377 | 8,901,804 | 2,127,969 | Dec 15, 2021, 09:48 PM | |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | Director | Dec 08, 2021 | Sale | $33.25 | 42,458 | 1,411,871 | 2,232,251 | Dec 10, 2021, 09:22 PM | |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | Director | Dec 09, 2021 | Sale | $32.03 | 76,905 | 2,463,502 | 2,219,268 | Dec 10, 2021, 09:22 PM | |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | Director | Dec 10, 2021 | Sale | $31.31 | 26,274 | 822,719 | 2,155,944 | Dec 10, 2021, 09:22 PM | |
| ALXO | ALX ONCOLOGY HOLDINGS INC | Lettmann Jason | Director | Jul 21, 2020 | Buy | $19.00 | 400,000 | 7,600,000 | 378,000 | Jul 21, 2020, 09:31 PM | |
| RARX | Ra Pharmaceuticals, Inc. | Lettmann Jason | Director | Oct 31, 2016 | Buy | $11.22 | 457,282 | 5,129,830 | 4,066,503 | Oct 31, 2016, 04:51 PM |
Menu